Cardiff Oncology Inc - Company Profile
Powered by
All the data and insights you need on Cardiff Oncology Inc in one report.
- Save hours of research time and resources with
our up-to-date Cardiff Oncology Inc Strategy Report
- Understand Cardiff Oncology Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Cardiff Oncology Inc (Cardiff Oncology), formerly Trovagene Inc is a clinical-stage oncology therapeutics company that focuses on developing therapies for cancer. Focus on R&D, lead product candidate: Onvansertib and patent portfolio are the key strength of the company, whereas history of operating losses and working capital decline could be a cause for concern to the company. Nevertheless, Cardiff Oncology could capture growth opportunities from growing incidence from cancer, market potential: chronic myeloid leukemia, rising healthcare expenditure in the us. However, Government regulations, intense competition, and dearth of skilled healthcare professionals outcomes could affect its operational performance.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer